PharmaBlock Sciences (Nanjing), Inc.
SHZ: 300725.SZ0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Shenzhen Stock Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Minmin Yang
- Employees
- 2,455
- Headquarters
- Nanjing, China
- IPO year
- 2017
- Market cap
- CN¥7.8B
- Website
- https://www.pharmablock.com
Loading 300725…
Loading profile data…Frequently asked questions about 300725
What does PharmaBlock Sciences (Nanjing), Inc. (300725.SZ) do?
PharmaBlock Sciences (Nanjing), Inc. provides chemistry products and services throughout the pharmaceutical research and development, and commercial production. It primarily businesses include building blocks collection, supplying from discovery, development to commercial; building blocks driven libraries for drug discovery; development and manu...
Where does 300725.SZ trade?
PharmaBlock Sciences (Nanjing), Inc. (300725.SZ) trades on the Shenzhen Stock Exchange.
What sector is 300725.SZ in?
PharmaBlock Sciences (Nanjing), Inc. (300725.SZ) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of PharmaBlock Sciences (Nanjing), Inc.?
Minmin Yang is the chief executive officer of PharmaBlock Sciences (Nanjing), Inc. (300725.SZ).
Where is PharmaBlock Sciences (Nanjing), Inc. headquartered?
PharmaBlock Sciences (Nanjing), Inc. is headquartered in China.
Does 300725.SZ pay a dividend?
Yes — PharmaBlock Sciences (Nanjing), Inc. (300725.SZ) paid a trailing twelve-month dividend of CNY 0.28 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 300725.SZ go public?
PharmaBlock Sciences (Nanjing), Inc. (300725.SZ) completed its initial public offering in 2017.